Your browser doesn't support javascript.
loading
Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population-based cohort studies in Japan.
Koyanagi, Yuriko N; Matsuo, Keitaro; Ito, Hidemi; Wang, Chaochen; Tamakoshi, Akiko; Sugawara, Yumi; Tsuji, Ichiro; Ono, Ayami; Tsugane, Shoichiro; Sawada, Norie; Wada, Keiko; Nagata, Chisato; Takeuchi, Taro; Kitamura, Tetsuhisa; Utada, Mai; Sakata, Ritsu; Mizoue, Tetsuya; Abe, Sarah Krull; Inoue, Manami.
Afiliação
  • Koyanagi YN; Division of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Matsuo K; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Ito H; Department of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Wang C; Division of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Tamakoshi A; Division of Descriptive Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Sugawara Y; Japan Value, Evidence and Outcomes, Japan Drug Development and Medical Affairs Eli Lilly Japan K.K., Kobe, Japan.
  • Tsuji I; Department of Public Health, Hokkaido University Faculty of Medicine, Sapporo, Japan.
  • Ono A; Division of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Tsugane S; Division of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Sawada N; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Wada K; Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Nagata C; National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan.
  • Takeuchi T; Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Kitamura T; Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Utada M; Department of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Sakata R; Department of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Mizoue T; Department of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Abe SK; Department of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.
  • Inoue M; Department of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.
Cancer Sci ; 114(7): 2961-2972, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37013939
ABSTRACT
The effect of body mass index (BMI) on esophageal and gastric carcinogenesis might be heterogeneous, depending on subtype or subsite. However, findings from prospective evaluations of BMI associated with these cancers among Asian populations have been inconsistent and limited, especially for esophageal adenocarcinoma and gastric cardia cancer. We performed a pooled analysis of 10 population-based cohort studies to examine this association in 394,247 Japanese individuals. We used Cox proportional hazards regression to estimate study-specific hazard ratios (HRs) and 95% confidence intervals (CIs), then pooled these estimates to calculate summary HRs with a random effects model. During 5,750,107 person-years of follow-up, 1569 esophageal cancer (1038 squamous cell carcinoma and 86 adenocarcinoma) and 11,095 gastric (728 cardia and 5620 noncardia) cancer incident cases were identified. An inverse association was observed between BMI and esophageal squamous cell carcinoma (HR per 5-kg/m2 increase 0.57, 95% CI 0.50-0.65), whereas a positive association was seen in gastric cardia cancer (HR 1.15, 95% CI 1.00-1.32). A nonsignificant and significant positive association for overweight or obese (BMI ≥25 kg/m2 ) relative to BMI <25 kg/m2 was observed with esophageal adenocarcinoma (HR 1.32, 95% CI 0.80-2.17) and gastric cardia cancer (HR 1.24, 95% CI 1.05-1.46), respectively. No clear association with BMI was found for gastric noncardia cancer. This prospective study-the largest in an Asian country-provides a comprehensive quantitative estimate of the association of BMI with upper gastrointestinal cancer and confirms the subtype- or subsite-specific carcinogenic impact of BMI in a Japanese population.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão